Comparative effect of 1.2% atorvastatin gel and 1.2% rosuvastatin as a local drug delivery in treatment of intra-bony defects in chronic periodontitis

Indian J Dent Res. 2022 Apr-Jun;33(2):180-183. doi: 10.4103/ijdr.ijdr_25_21.

Abstract

Background: The present study was aimed to evaluate the efficacy of 1.2% Atorvastatin (ATV) with 1.2% Rosuvastatin (RSV) as local drug delivery for treatment of Chronic Periodontitis (CP).

Materials and methods: Forty patients were equally divided into two groups. Group A underwent scaling and root debridement and 1.2% ATV gel (1.2 mg/0.1 mL) was placed, whereas group B received scaling and root debridement and RSV (1.2 mg/0.1 ml) was placed.

Results: The results showed that both the groups had improvement in all the recorded parameters, and the results obtained were statistically significant. When comparison was made between the groups, no significant difference was obtained between atorvastatin and rosuvastatin at baseline in all recorded parameters. However, after 6 months significant improvement was recorded in CAL (Clinical attachment level) and PD (Probing depth). The plaque index (PI) and gingival index (GI) score however showed improvement, but it did not attain the level of significance.

Conclusion: The present study showed improvement in clinical parameters with the use of ATV and RSV gel when used in combination with scaling and root planing (SRP) in CP patients. Patients with RSV gel showed up significantly better than the ones in which ATV gel was placed.

Keywords: Atorvastatin gel; chronic periodontitis; rosuvastatin.

MeSH terms

  • Atorvastatin / therapeutic use
  • Chronic Periodontitis* / drug therapy
  • Dental Scaling / methods
  • Humans
  • Root Planing / methods
  • Rosuvastatin Calcium / therapeutic use
  • Treatment Outcome

Substances

  • Rosuvastatin Calcium
  • Atorvastatin